Not enough buy signals with a settled T+90 horizon to measure a track record yet.
No signal scores available.
Explore the detailed record of transactions filed by Cantley Lewis Clayton Jr.. Director active across 1 company, notably AGIOS PHARMACEUTICALS INC. Aggregated, 4 disclosures have been recorded. Breakdown: 0 buy · 4 sells. Regulator: SEC (Form 4). All data is openly available.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
4 of 4 declarations
Cantley Lewis Clayton Jr. is a declarant linked to AGIOS PHARMACEUTICALS INC, where he is a Director. The record shows 4 filings in total, and the recent filings available run from 2016-02-01 to 2016-02-01, all of them sales.